Quantum Cyber N.V.
QUCYNasdaqHealthcare · Pharmaceutical Preparations · P7 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | |
|---|---|---|
| Revenue | $537,080 | $893,991 |
| Operating income | −$16.1M | −$18.8M |
| Net income | −$16.2M | −$21.6M |
| Total assets | $5.3M | $13.5M |
| Total liabilities | $4.7M | $7.5M |
| Equity | $641,600 | $6.0M |
| EPS (diluted) | $-2.70 | $-21.91 |
| Shares out. | 9.8M | 2.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −3005.0%
- Net margin
- −3018.3%
- Return on equity
- −2526.6%
- Return on assets
- −304.3%
- Return on capital (ROCE)
- −987.7%
- Liabilities / assets
- 88.0%
- Debt / equity
- 7.30×
- Book value / share
- $0.07
- Revenue growth (YoY)
- −39.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -86.69distress
- Accruals / assets
- −98.2%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗May 2, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lazar David E.Activist (13D)Apr 28, 2026
- Armistice Capital, LlcPassive (13G)Feb 17, 2026
- Donahue Kevin MichaelPassive (13G)Jan 20, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Ben-Tzvi AvrahamDirector | May 8, 2026 | Grant | 137,141 | $0.00 |
| Natan DavidDirector | May 8, 2026 | Grant | 137,141 | $0.00 |
| Caragol William JOfficer — Chief Financial Officer | Feb 13, 2026 | Grant | 290,000 | $0.00 |
| Dreismann HeinrichDirector | Feb 13, 2026 | Grant | 45,000 | $0.00 |
| Tibbitts Gregory JDirector | Feb 13, 2026 | Grant | 45,000 | $0.00 |
| Baechler GuidoOfficer — Chief Executive Officer | Feb 13, 2026 | Grant | 440,000 | $0.00 |
| Donahue Kevin Michael10% owner | Oct 17, 2025 | Buy | 643,850 | $402000.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 10.5M | 1.0 | +996.3% |
| Apr 30, 2026 | 960,587 | 1.0 | +40.3% |
| Apr 15, 2026 | 684,848 | 1.0 | +148.9% |
| Mar 31, 2026 | 275,109 | 1.0 | -41.9% |
| Mar 13, 2026 | 473,566 | 1.0 | +1.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 28, 2026
- Other material eventMay 26, 2026
- Entered a material agreement · Director / officer changeMay 18, 2026
- Entered a material agreement · Director / officer changeMay 8, 2026
- Entered a material agreement · Unregistered equity sale · Change in control · Director / officer change · Amended charter or bylaws · Shareholder voteApr 28, 2026
- Entered a material agreement · Other material eventApr 15, 2026
- Delisting / listing-standard noticeMar 25, 2026
- Regulation FD disclosure · Other material eventMar 17, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- DEF 14ADEFINITIVE PROXY STATEMENTJun 1, 2026
- ARSFORM ARSJun 1, 2026
- 8-KCURRENT REPORTMay 28, 2026
- 4May 26, 2026
- 8-KCURRENT REPORTMay 26, 2026
- PRE 14APRELIMINARY PROXY STATEMENTMay 22, 2026
- 144May 22, 2026
- 3May 21, 2026
- 4May 21, 2026
- 144May 18, 2026
- 8-KCURRENT REPORTMay 18, 2026
- 10-QQUARTERLY REPORTMay 15, 2026
- 8-KCURRENT REPORTMay 8, 2026
- 3Apr 28, 2026
- 3Apr 28, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.